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crosis factor-  and IFN-  . In conclusion, the reciprocal acti-
vating interaction between human DCs and NK cells may 
play a pivotal role in the immune defense against viruses and 
tumors.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Dendritic cells (DCs) are professional antigen-pre-
senting cells, which display an extraordinary capacity to 
induce and stimulate CD8 + cytotoxic T lymphocytes 
(CTLs) and CD4 + T cells  [1] . CD8 + CTLs efficiently rec-
ognize and destroy virus-infected and tumor cells, which 
expose antigen-derived peptides in complex with human 
leukocyte antigen (HLA) class I molecules. CD4 + T cells 
recognizing peptides in the context of HLA class II mol-
ecules also play an important role in adaptive immunity. 
CD4 + T cells improve the capacity of DCs to induce CTLs 
and directly support the expansion of CTLs by secreting 
cytokines such as interleukin (IL)-2. Owing to their 
unique T-cell-stimulatory capacity, DCs evolved as prom-
ising candidates for vaccination protocols in tumor ther-
apy. Animal models demonstrated that tumor-associated 
antigen-presenting DCs are capable of inducing protec-
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 Abstract 
 Dendritic cells (DCs) are professional antigen-presenting 
cells, which display an extraordinary capacity to induce T-cell 
responses. Recent findings revealed that DCs also play a cru-
cial role in the activation of natural killer (NK) cells represent-
ing important effectors in the innate immune defense 
against viruses and tumors. Here, we summarize various 
studies investigating the bidirectional crosstalk between hu-
man DCs and NK cells. In this context, it has been reported 
that DCs efficiently enhance CD69 expression, proliferation, 
interferon (IFN)-  secretion and cytotoxic activity of NK cells. 
Cell membrane-associated molecules as well as soluble fac-
tors such as interleukin-12, tumor necrosis factor-  and type 
I IFNs contributed to DC-mediated NK cell activation. Recip-
rocally, the ability of human NK cells to enhance the immu-
nostimulatory capacity of DCs was shown. Thus, NK cells pro-
moted the maturation of DCs and markedly augmented 
their capacity to produce proinflammatory cytokines and to 
stimulate T-cell responses. The NK cell-mediated effects on 
DCs were dependent on cell membrane-associated mole-
cules such as NKp30 and soluble factors such as tumor ne-
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tive and therapeutic antitumor responses  [2] . In addition, 
clinical trials enrolling tumor patients revealed promis-
ing immunologic and clinical responses of tumor-associ-
ated antigen-loaded DCs administered as a vaccine  [3] .
 Recent findings indicated that DCs also play an im-
portant role in the activation of natural killer (NK) cells, 
which represent important effectors in innate immunity 
 [4] . Human blood NK cells can be subdivided into two 
distinct subsets based on the cell surface density of CD56 
expression  [5] . CD56 dim CD16 + NK cells represent the 
majority (approximately 90%) of NK cells and have a high 
cytotoxic capacity. CD56 bright CD16 – NK cells comprise 
approximately 10% of NK cells and produce high levels of 
cytokines such as interferon (IFN)-  and tumor necrosis 
factor (TNF)-  , which play an important role in modu-
lating immune responses. Due to their functional prop-
erties, NK cells essentially contribute to the elimination 
of tumor and virus-infected cells. When investigating the 
potential of mouse DCs to stimulate NK cells, it has been 
reported that FMS-like tyrosine kinase 3 ligand-expand-
ed or adoptively transferred DCs markedly enhance NK 
cell-dependent antitumor effects in mice with major his-
tocompatibility complex class-I-negative tumors  [6] . Fol-
lowing such findings, the bidirectional crosstalk between 
human DCs and NK cells has been explored. The results 
are summarized in this review article.
 Human DCs Improve Effector Functions of NK Cells 
 In recent years, several studies investigated the poten-
tial of human DCs to influence phenotype and function 
of NK cells. Most of these analyses were performed with 
monocyte-derived DCs. To obtain immature DCs, mono-
cytes were maintained for several days in the presence of 
granulocyte macrophage colony-stimulating factor and 
IL-4. For maturation and stimulation, immature DCs 
were cultivated in the presence of additional factors such 
as TNF-  , IL-1  , IFN-  , lipopolysaccharide (LPS) and 
polyinosinic-polycytidylic acid. It has been demonstrated 
that monocyte-derived DCs markedly enhance the ex-
pression of the activation marker CD69 on the surface of 
NK cells  [7–12] . Soluble factors such as type I IFNs as well 
as direct cell-to-cell contact were shown to be important 
for DC-mediated upregulation of CD69 on NK cells  [7–9, 
12] . Thus, major histocompatibility complex class-I-relat-
ed chain (MIC) A and B representing ligands for the ac-
tivating NK cell receptor NKG2D were induced on mono-
cyte-derived DCs upon IFN-  stimulation and contrib-
uted to the upregulation of CD69 on NK cells  [9] . More 
recently, it has been reported that the recognition of in-
fluenza-infected monocyte-derived DCs by the activat-
ing NK cell receptors NKG2D and NKp46 results in an 
increased CD69 expression on NK cells  [12] .
 Further studies revealed that human monocyte-de-
rived DCs are also able to efficiently promote NK cell 
proliferation  [10, 13–17] . When distinguishing between 
CD56 dim CD16 + and CD56 bright CD16 – NK cell subsets, 
Vitale et al.  [10] demonstrated that activated monocyte-
derived DCs only increased expansion of CD56 bright 
CD16 – NK cells. In contrast, IL-2 induced a non-selected, 
homogeneous proliferation of both NK cell populations. 
Cell-to-cell contact essentially contributed to DC-medi-
ated NK cell proliferation. Thus, it has been documented 
that the interaction between CD40 on DCs and CD40L 
on NK cells as well as B7 molecules on DCs and CD28 on 
NK cells plays an important role  [13] . IL-15 expressed on 
the surface of activated monocyte-derived DCs also me-
diated enhanced NK cell proliferation  [15] . In addition, 
IL-12 contributed to this effect  [13] .
 Further studies explored the potential of monocyte-
derived DCs to modulate cytokine production of NK 
cells. Monocyte-derived DCs induced the release of IFN-
  by NK cells  [9, 10, 12–15, 17–19] . When investigating 
the underlying mechanisms, it has been demonstrated 
that IL-12 essentially contributes to this effect  [9, 10, 12, 
13, 15, 18] . DC-mediated induction of IFN-  production 
by NK cells also required direct cell-to-cell contact  [12] . 
Recently, Borg et al.  [18] reported that the formation of 
stimulatory synapses promoted the polarized secretion of 
preassembled stores of IL-12 by DCs towards NK cells. In 
this context, the interaction of CX3CL1 expressed by DCs 
and CX3CR1 on NK cells induced DC-mediated IFN-  
production by NK cells  [19] . However, whereas IL-12 
plays a major role for the induction of NK cell IFN-  se-
cretion by LPS-activated DCs, other factors appear to be 
important for IFN-  -stimulated DCs mediating the same 
effect. Thus, it has been shown that the expression of the 
NKG2D ligands MICA and MICB on IFN-  -treated DCs 
is responsible for the induction of IFN-  production by 
NK cells  [9] . In addition, Draghi et al.  [12] reported that 
NK cell IFN-  secretion mediated by influenza virus-in-
fected DCs is dependent on the ligation of the activating 
NK cell receptors NKp46 and NKG2D.
 The cytotoxic potential of NK cells plays an important 
role in the elimination of virus-infected and tumor cells. 
Therefore, the impact of human monocyte-derived DCs 
on the cytotoxic activity of NK cells was investigated. It 
has been documented that DCs efficiently improve this 
functional property of NK cells  [8, 9, 12, 13, 16, 17, 19, 20] . 
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The DC-mediated enhancement of NK cell cytolytic ac-
tivity was mediated by soluble factors and direct cell-to-
cell contact  [8, 13, 20] . Thus, IL-12 secreted by activated 
DCs as well as CX3CL1, MICA and MICB expressed on 
the surface of DCs contributed to the improved cytolytic 
potential of NK cells  [9, 13, 19] . Besides efficient tumor 
cell killing, activated NK cells were also able to lyse 
monocyte-derived DCs  [12, 14, 21–23] . Mature DCs were 
less sensitive to NK cell-mediated lysis, which was most 
probably due to a higher expression level of HLA class I 
molecules that bind to inhibitory NK cell receptors  [21] . 
Recognition of monocyte-derived DCs was mainly medi-
ated through NKp30 and to a lesser extent by NKp46
and NKG2D  [14] . Further studies demonstrated that ad-
ditional activating NK cell receptors such as CD94/
NKD2A and DNAX accessory molecule 1 are involved in 
NK cell-mediated lysis of DCs  [21, 23] .
 In addition to monocyte-derived DCs, the potential of 
human DCs derived from CD34 + cord blood cells to 
modulate the effector functions of NK cells was investi-
gated  [24] . For this, DCs were generated from CD34 + cord 
blood cells after several days in the presence of various 
cytokines. Yu et al.  [24] demonstrated the capability of 
CD34 + cell-derived DCs to significantly improve the tu-
mor-directed cytotoxicity and IFN-  secretion of NK 
cells. Cell-to-cell contact as well as IL-12 and IL-18 se-
creted by DCs contributed to these effects.
 Whereas most current findings are based on mono-
cyte-derived DCs, which are generated after several days 
in the presence of various cytokines, studies investigating 
the interaction between native human DCs and NK cells 
are limited. Several studies provided evidence that native 
human myeloid and plasmacytoid blood DCs  [25, 26] ef-
ficiently promote NK cell activation. Thus, it has been 
demonstrated that polyinosinic-polycytidylic acid-stim-
ulated CD1c + myeloid DCs and CD1c + /BDCA-3 + myeloid 
DCs strongly increased CD69 expression, IFN-  secre-
tion and tumor-directed cytotoxicity of NK cells  [27, 28] . 
Whereas type I IFNs and IL-12 were critical for improved 
cytolytic activity of NK cells, increased CD69 expression 
was dependent on type I IFNs and TNF-  . Furthermore, 
IL-12 and cell-to-cell contact essentially contributed to 
CD1c + DC-mediated enhancement of IFN-  secretion by 
NK cells  [27, 28] . Recently, we documented the ability of 
LPS-stimulated 6-sulfo LacNAc + (slan) DCs, which rep-
resent another myeloid blood DC subset  [29, 30] , to effi-
ciently activate resting NK cells  [31] . LPS-stimulated 
slanDCs augmented the surface expression of CD69 and 
markedly improved IFN-  release as well as tumor-di-
rected cytotoxicity of NK cells  [31] . When evaluating the 
underlying mechanisms for NK cell activation by slan-
DCs in response to LPS, we found that IL-12 plays a cru-
cial role in this process. However, in contrast to slanDCs 
activated by LPS, IFN-  -stimulated slanDCs improve 
NK cell activation through cell-to-cell contact  [32] . When 
investigating native plasmacytoid DCs  [26] , it has been 
reported that inactivated influenza virus- or CpG oligo-
deoxynucleotide-stimulated plasmacytoid DCs promote 
CD69 expression, proliferation, IFN-  secretion and tu-
moricidal potential of NK cells  [27, 33, 34] . Type I IFNs 
and TNF-  released by plasmacytoid DCs were critical 
for enhanced CD69 expression on NK cells  [27, 33] . Cell-
to-cell contact as well as soluble molecules such as type I 
IFNs and glucocorticoid-induced TNF receptor ligand 
contributed to the ability of plasmacytoid DCs to aug-
ment IFN-  secretion and cytotoxic activity of NK cells 
 [27, 33, 34] .
 NK Cells Efficiently Promote the Immunostimulatory 
Properties of Human DCs 
 Recent data illustrated the potential of NK cells to en-
hance the immunostimulatory capacity of DCs. In this 
context, it has been shown that NK cells efficiently pro-
mote the differentiation and maturation of monocyte-
derived DCs  [7, 22, 35–39] . This NK cell-mediated effect 
on DCs was dependent on the engagement of the cell 
membrane-associated activating NK cell receptor NKp30 
and soluble factors such as TNF-  , IFN-  and high-mo-
bility group box protein 1  [7, 8, 22, 35, 36, 39] .
 Further studies demonstrated that NK cells signifi-
cantly augment the production of immunostimulatory 
cytokines by human monocyte-derived DCs. Thus, it has 
been reported that NK cells markedly increase TNF-  
release by DCs, which is based on cell-to-cell contact  [7, 
38] . Furthermore, the capacity of DCs to produce IL-12 
was profoundly enhanced by NK cells  [7, 8, 35] . Cell-to-
cell contact as well as IFN-  and TNF-  contributed to 
this effect  [7, 35] .
 Following the findings that NK cells promote matura-
tion and cytokine production of monocyte-derived DCs, 
the impact of NK cells on DC-mediated T-cell prolifera-
tion and differentiation was explored. Several studies 
showed that NK cells markedly improve the capability of 
monocyte-derived DCs to stimulate T-cell proliferation, 
to differentiate naïve CD4 + T lymphocytes into IFN-  -
producing Th1 cells and to promote IFN-  production by 
CD8 + CTLs  [8, 35, 38] .
 Interaction between Dendritic Cells and 
Natural Killer Cells 
J Innate Immun 2011;3:258–263 261
 When evaluating the impact of NK cells on native hu-
man DCs, Gerosa et al.  [27] documented that NK cells 
promote the maturation of CD1c + myeloid DCs, which is 
dependent on cell-to-cell contact. However, the secretion 
of IL-12 by CD1c + myeloid DCs was not induced by NK 
cells. Furthermore, we demonstrated that NK cells effi-
ciently promote the maturation of myeloid slanDCs in 
the absence of exogenous cytokines  [31] . NK cells also 
profoundly enhanced the secretion of IL-12 and reduced 
the production of the immunosuppressive cytokine IL-10 
by slanDCs. IFN-  released by NK cells as well as cell-to-
cell contact contributed to these effects. Further data re-
vealed that the crosstalk between slanDCs and NK cells 
improved the capacity of LPS-stimulated slanDCs to fa-
vor the differentiation of naïve CD4 + T cells into IFN-  -
producing Th1 cells  [31] . Studies investigating the impact 
of NK cells on phenotype and function of plasmacytoid 
DCs illustrated that NK cells promote DC maturation 
and strongly enhance IFN-  and TNF-  production by 
this DC subset in the presence of suboptimal CpG oligo-
deoxynucleotide concentrations  [27] . Cell-to-cell contact 
was essential for these effects. Furthermore, it has been 
reported that NK cells promote IFN-  and IL-6 release 
by plasmacytoid DCs  [40] .
 Conclusion 
 DCs are professional antigen-presenting cells, which 
display an extraordinary capacity to induce and maintain 
T-cell responses. Recent findings revealed that DCs also 
play a crucial role in the activation of NK cells represent-
ing important effectors in the innate immune defense 
against viruses and tumors. In this context, it has been 
demonstrated that human monocyte-derived DCs as well 
as native human DCs in response to different stimuli ef-
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 Fig. 1. Bidirectional crosstalk between human DCs and NK cells. 
DCs efficiently enhance CD69 expression, proliferation, IFN-  
production and cytotoxic activity of NK cells. Cell membrane-
associated molecules like MICA and MICB as well as soluble fac-
tors like IL-12 and type I IFNs contributed to DC-mediated NK 
cell activation. Reciprocally, NK cells promote DC maturation 
and improve their capability to secrete proinflammatory cyto-
kines and to stimulate T-cell responses. The NK cell-mediated 
effects on DCs are dependent on cell membrane-associated mol-
ecules such as NKp30 and soluble factors such as IFN-  and TNF-
  . HMGB-1 = High-mobility group box protein 1; GITRL = glu-
cocorticoid-induced TNF receptor-ligand; DNAM-1 = DNAX ac-
cessory molecule 1. 
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ficiently improve CD69 expression, proliferation, IFN-  
secretion and cytotoxic activity of NK cells ( fig. 1 ). These 
DC-mediated effects are critically dependent on cell 
membrane-associated molecules as well as on soluble 
molecules ( fig. 1 ). Interestingly, the contribution of the 
various molecules is critically dependent on the DC sub-
set as well as on the stimulus used for DC activation. Re-
ciprocally, it has been shown that NK cells promote mat-
uration and enhance the secretion of proinflammatory 
cytokines by monocyte-derived DCs and native human 
DCs ( fig. 1 ). Cell membrane-associated molecules as well 
as soluble molecules contributed to these NK cell-medi-
ated effects ( fig. 1 ). Furthermore, NK cells markedly en-
hanced the capacity of DCs to stimulate and differentiate 
T cells. All these findings demonstrate a reciprocal acti-
vating crosstalk between human DCs and NK cells, 
which may play a pivotal role in the regulation of the im-
mune defense against viruses and tumors. They may also 
pave the way for the design of novel immunotherapeutic 
strategies for the treatment of infectious diseases and tu-
mors.
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